Ketamine has been used as an anesthetic before surgeries for decades, but it can also be an option for those struggling with ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

FDA approves esketamine nasal spray as a standalone treatment for adults with treatment-resistant depression, offering rapid ...

He tried antidepressants and cannabis, but they weren't as effective as esketamine therapy. "I feel like I'm a better dad, I can actually have a conversation without getting overly worked up and ...

He tried antidepressants and cannabis, but they weren't as effective as esketamine therapy. "It's changed my life tremendously," Patterson said. "I feel like I'm a better dad, I can actually have a ...

The results, which come on the heels of the FDA’s approval of J&J’s esketamine nasal spray Spravato as a monotherapy for ...

the therapy’s mechanism of action aims to address this unmet need with its nonselective, noncompetitive antagonist of the NMDA receptor. Approved in 77 countries, esketamine is indicated for ...

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

The expanded indication allows esketamine nasal spray to be used as a standalone treatment in adults with MDD who have not ...

Medicaid in Wisconsin has expanded to cover ketamine infusions as of Jan. 1, sparking conversations about the nuances in type ...